Stephen J Forman's most recent trade in Lixte Biotechnology Holdings Inc was a trade of 10,000 Options to Purchase Common Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lixte biotech Holdings Inc | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 7,754 | 7,754 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 5,851 | 5,851 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2025 | 3,030 | 3,030 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Stephen J. Forman | Director | 30 Sep 2024 | 3,858 | 3,858 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Stephen J. Forman | Director | 30 Jun 2024 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Stephen J. Forman | Director | 30 Jun 2024 | 3,018 | 3,018 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Stephen J. Forman | Director | 30 Jun 2023 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Stephen J. Forman | Director | 30 Jun 2022 | 100,000 | 100,000 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Stephen J. Forman | Director | 22 Apr 2021 | 33,334 | 58,137 | - | 1.0 | 32,001 | Common Stock |